First Page | Document Content | |
---|---|---|
![]() Antifungals Piperazines Organochlorides Triazoles Organofluorides Basilea Pharmaceutica Cephalosporin Ceftobiprole Methicillin-resistant Staphylococcus aureus Organic chemistry Chemistry Microbiology | Add to Reading List |
![]() | pwc_master_logo_shortformDocID: 1ab38 - View Document |
![]() | Microsoft Word - 20150424_FINAL_ECCMID_EN_with links.docxDocID: 1a62K - View Document |
![]() | PRESS RELEASE Swissmedic approves Basilea’s antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia Basel, Switzerland, December 22, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that theDocID: R3t7 - View Document |
![]() | Microsoft Word - 20141205_Basilea_Ceftobiprole launch Germany_EN.docxDocID: Qg0Q - View Document |
![]() | Microsoft Word - 20150217_Basilea_FYR14_EN.docxDocID: Q7FF - View Document |